Marker of mammalian target of rapamycin (mTOR) pathway activity. Aminoimidazole carboxamide ribonucleotide therapy was also
Marker of mammalian target of rapamycin (mTOR) pathway activity. Aminoimidazole carboxamide ribonucleotide therapy was also related with downregulation of cyclins A and D, but had minimal effects on the phosphorylation…